Nontyphoidal Salmonella Invasive Disease: Challenges and Solutions
Open Forum Infectious Diseases · 02.06.2023 · 10 (Supplement_1) · S32-S37
DOI: 10.1093/ofid/ofad020 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 02.06.2023. Verfasst von John A Crump und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for International Health, University of Otago, Dunedin, New Zealand. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Bill & Melinda Gates Foundation, US National Institutes of Health.
Abstract (Originalsprache)
Nontyphoidal Salmonella are a leading cause of community-onset bacteremia and other serious infections in sub-Saharan African countries where large studies indicate that they are an uncommon cause of moderate-to-severe diarrhea. Approximately 535 000 nontyphoidal Salmonella invasive disease illnesses and 77 500 deaths were estimated to occur in 2017; 422 000 (78.9%) illnesses and 66 500 (85.9%) deaths in countries in sub-Saharan Africa. Lineages of Salmonella enterica serovar Typhimurium sequence type (ST) 313 and lineages of Salmonella enterica serovar Enteritidis ST11 dominate as causes of invasive disease. A major reservoir for these specific strains outside of humans has not been identified to date. Human fecal shedding of such strains is common in areas where nontyphoidal Salmonella invasive disease incidence is high. The case-fatality ratio of nontyphoidal Salmonella invasive disease is approximately 15%. Early diagnosis and treatment are needed to avert fatal outcomes. Antimicrobial resistance, including multiple drug resistance, decreased fluoroquinolone susceptibility, and resistance to third-generation cephalosporins, is increasing in prevalence and is likely to further compromise patient outcomes. Naturally acquired immunity against invasive disease develops in children aged >3 years in endemic areas, likely mediated in part by the sequential acquisition of T-cell immunity, followed by antigen-specific immunoglobulin G antibodies. Vaccines in preclinical or clinical development include live-attenuated S. enterica serovar Typhimurium, nontyphoidal S. enterica core and O-polysaccharide glycoconjugates, multiple antigen-presenting system complexes, and generalized modules for membrane antigens vaccines. The latter are in phase I trials in Europe and Africa. Both vaccine use, and other effective, evidence-based nonvaccine interventions, are needed to prevent and control nontyphoidal Salmonella invasive disease.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for International Health, University of Otago, Dunedin, New Zealand.
- Department of Pathology, Kamuzu University of Health Sciences, Blantyre, Malawi.
- Department of Medical Biology, University Hospital of Kinshasa, Kinshasa, Democratic Republic of the Congo.
- Department of Microbiology, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.
- Department of Clinical Science, Institute of Tropical Medicine, Antwerp, Belgium.
- Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
ORCID-Profile: John A Crump, Tonney S Nyirenda, Lisette Mbuyi Kalonji, Marie-France Phoba, Bieke Tack, James A Platts-Mills, Melita A Gordon, Samuel M Kariuki
Förderung
- NIAID NIH HHS
- Bill & Melinda Gates Foundation
- US National Institutes of Health
- Research Foundation—Flanders
- FWO
- European Society of Clinical Microbiology and Infectious Diseases
- EU Horizon 2020 Research and Innovation Programme
Zitieren
APA
Crump, J. A., Nyirenda, T. S., Kalonji, L. M., Phoba, M. F., Tack, B., Platts-Mills, J. A., Gordon, M. A., & Kariuki, S. M. (2023). Nontyphoidal Salmonella Invasive Disease: Challenges and Solutions. Open Forum Infectious Diseases, 10(Supplement_1), S32-S37. https://doi.org/10.1093/ofid/ofad020
Vancouver
Crump JA, Nyirenda TS, Kalonji LM, Phoba MF, Tack B, Platts-Mills JA, et al. Nontyphoidal Salmonella Invasive Disease: Challenges and Solutions. Open Forum Infectious Diseases. 2023;10(Supplement_1):S32-S37. doi:10.1093/ofid/ofad020
BibTeX
@article{Crump2023,
author = {Crump, John A and Nyirenda, Tonney S and Kalonji, Lisette Mbuyi and Phoba, Marie-France and Tack, Bieke and Platts-Mills, James A and Gordon, Melita A and Kariuki, Samuel M},
title = {Nontyphoidal Salmonella Invasive Disease: Challenges and Solutions},
journal = {Open Forum Infectious Diseases},
year = {2023},
volume = {10},
number = {Supplement_1},
pages = {S32--S37},
doi = {10.1093/ofid/ofad020}
}
EUVIMED